Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish

  1. Sharan Janjuha
  2. Sumeet Pal Singh
  3. Anastasia Tsakmaki
  4. S Neda Mousavy Gharavy
  5. Priyanka Murawala
  6. Judith Konantz
  7. Sarah Birke
  8. David J Hodson
  9. Guy A Rutter
  10. Gavin A Bewick
  11. Nikolay Ninov  Is a corresponding author
  1. Technische Universität Dresden, Germany
  2. King's College London, United Kingdom
  3. Imperial College London, United Kingdom
  4. University of Birmingham, United Kingdom

Abstract

The pancreatic islet, a cellular community harboring the insulin-producing beta-cells, is known to undergo age-related alterations. However, only a handful of signals associated with aging have been identified. By comparing beta-cells from younger and older zebrafish, here we show that the aging islets exhibit signs of chronic inflammation. These include recruitment of tnfα-expressing macrophages and the activation of NF-kB signaling in beta-cells. Using a transgenic reporter, we show that NF-kB activity is undetectable in juvenile beta-cells, whereas cells from older fish exhibit heterogeneous NF-kB activity. We link this heterogeneity to differences in gene expression and proliferation. Beta-cells with high NF-kB signaling proliferate significantly less compared to their neighbors with low activity. The NF-kB signalinghi cells also exhibit premature upregulation of socs2, an age-related gene that inhibits beta-cell proliferation. Together, our results show that NF-kB activity marks the asynchronous decline in beta-cell proliferation with advancing age.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Sharan Janjuha

    Paul Langerhans Institute Dresden of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Sumeet Pal Singh

    Centre for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5154-3318
  3. Anastasia Tsakmaki

    Diabetes Research Group, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. S Neda Mousavy Gharavy

    Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology, and Metabolism and Consortium for Islet Cell Biology and Diabetes, Department of Medicine, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Priyanka Murawala

    Centre for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Judith Konantz

    Centre for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Sarah Birke

    Centre for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. David J Hodson

    Centre for Endocrinology, Diabetes, and Metabolism and Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8641-8568
  9. Guy A Rutter

    Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology, and Metabolism and Consortium for Islet Cell Biology and Diabetes, Department of Medicine, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Gavin A Bewick

    Diabetes Research Group, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4335-8403
  11. Nikolay Ninov

    Center for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany
    For correspondence
    nikolay.ninov@tu-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3286-6100

Funding

DFG-Center for Regenerative Therapies Dresden

  • Nikolay Ninov

German Center for Diabetes Research

  • Nikolay Ninov

Deutsche Forschungsgemeinschaft

  • Nikolay Ninov

European Foundation for the Study of Diabetes

  • Nikolay Ninov

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Marianne Bronner, California Institute of Technology, United States

Ethics

Animal experimentation: Experiments were conducted in accordance with the Animal Welfare Act and with permissionof the Landesdirektion Sachsen, Germany (AZ 24-9168, TV38/2015, A12/2016, A5/2017).

Version history

  1. Received: October 23, 2017
  2. Accepted: April 5, 2018
  3. Accepted Manuscript published: April 6, 2018 (version 1)
  4. Accepted Manuscript updated: April 10, 2018 (version 2)
  5. Version of Record published: May 9, 2018 (version 3)

Copyright

© 2018, Janjuha et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,886
    views
  • 637
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sharan Janjuha
  2. Sumeet Pal Singh
  3. Anastasia Tsakmaki
  4. S Neda Mousavy Gharavy
  5. Priyanka Murawala
  6. Judith Konantz
  7. Sarah Birke
  8. David J Hodson
  9. Guy A Rutter
  10. Gavin A Bewick
  11. Nikolay Ninov
(2018)
Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish
eLife 7:e32965.
https://doi.org/10.7554/eLife.32965

Share this article

https://doi.org/10.7554/eLife.32965

Further reading

    1. Cell Biology
    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.

    1. Cell Biology
    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.